[1]
J. C. Miralles-López, “Analysis of response of severe eosinophilic asthmatic patients to benralizumab”, Allergol Immunopathol, vol. 50, no. 6, pp. 163–168, Nov. 2022, doi: 10.15586/aei.v50i6.704.